Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: FMT for Multidrug Resistant Organism Reversal [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on using fecal microbiota transplantation (FMT) to reverse infections caused by multidrug-resistant organisms; completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Infection With Multi-drug Resistant Organisms | Phase 1 | Status: COMPLETED | Results posted: 2021-02-24